QA: ARATANA THERAPEUTICS INC. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509190_2018_ARATANA_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509190')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001509190, ARATANA THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 85,239,000
1 IntangibleAssetsNetIncludingGoodwill 47,911,000
2 PropertyPlantAndEquipmentNet 1,166,000
3 remainder_Assets 876,000
4 LiabilitiesCurrent 35,496,000
5 LiabilitiesNoncurrent 70,000
6 remainder_Liabilities 19,492,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 28,897,000
9 ResearchAndDevelopmentExpense 15,126,000
10 remainder_Expenses 26,006,000
11 remainder_Revenues 25,573,000
12 remainder_NetIncome -3,054,000
13 remainder_ComprehensiveNetIncome 2,777,000
  yvar yval
0 Assets 135,192,000
1 Liabilities 55,058,000
2 Expenses 70,029,000
3 Revenues 25,573,000
4 StockholdersEquity 80,134,000
5 NetIncome -47,510,000
6 ComprehensiveNetIncome -46,121,500
7 BaseVar 145,841,500
8 EconomicCapitalRatio 0.964

Edgar->Model Mapping

Feature Distribution

Change over Time